[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100508619":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":25,"locations":25,"responsibleParty":30,"collaborators":25,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":25,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":43,"enrollmentInfo":44,"targetDuration":25,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":59,"whyStopped":25,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":25},{"fullName":5,"class":6},"Benha University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group B (25 patients)","ACTIVE_COMPARATOR","In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of bupivacaine 0.125 % in a dose of 1ml\u002Fkg.",[13],"Drug: Caudal Bupivacaine injection",{"label":15,"type":10,"description":16,"interventionNames":17},"Group D (25 patients)","In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of dexmedetomidine in a dose of 1.5 mcg\u002Fkg.",[18],"Drug: Caudal Dexmedetomidine Injection",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Caudal Bupivacaine injection","\\- Group B (n =25): In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of bupivacaine 0.125 % in a dose of 1ml\u002Fkg.",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Caudal Dexmedetomidine Injection","\\- Group D (n =25): In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of dexmedetomidine in a dose of 1.5 mcg\u002Fkg.",[15],{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Nourhan Elsayed Mohamed Amer","Lecturer of Anesthesia at Faculty of Medicine, Benha University","100508619","can-caudal-dexmedetomidine-provide-effective-analgesia-100508619",false,"NCT05902780","Can Caudal Dexmedetomidine Provide Effective Analgesia?","Can Caudal Dexmedetomidine Provide Effective Analgesia During Pediatric Inguinoscrotal Surgery?","Inclusion Criteria:\n\n* ASA-I and ASA-II pediatric patients (age :1-6 years old)\n* Inguinoscrotal surgeries\n\nExclusion Criteria:\n\n* Patient's parent's refusal\n* Unable to give consent\n* Known allergy to the study medications\n* Coagulopathies or on anticoagulant medications\n* ASA-III or ASA-IV","ALL","1 Year","6 Years",{"count":45,"type":46},50,"ESTIMATED","INTERVENTIONAL",[49],"NA","The goal of this clinical trial is to evaluate if caudal dexmedetomidine can provide effective analgesia during inguinoscrotal surgeries in pediatrics, if used caudally alone (and not as an adjunct to caudal bupivacaine).\n\nThe main question it aims to answer is:\n\n* Can caudal dexmedetomidine provide effective analgesia? Participants will be pediatrics aged from 1 to 6 years ASA-I and ASA-II undergoing inguinoscrotal surgeries.\n\n  \\- A total of 50 pediatric patients who will undergo inguinoscrotal surgery will be allocated randomly into 2 equal groups:\n* Group B (n =25): In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of bupivacaine 0.125 % in a dose of 1ml\u002Fkg.\n* Group D (n =25): In this group, and after injection of general anesthesia, pediatric patients will receive a caudal injection of dexmedetomidine in a dose of 1.5 mcg\u002Fkg.",[52,53],"Anesthesia","Local Anesthesia",[52,55,56,57,58],"Caudal","Epidural","Regional","postoperative pain","NOT_YET_RECRUITING","2024-02-12",{"date":62,"type":63},"2024-02-13","ACTUAL",{"date":65,"type":46},"2024-09-01",{"date":67,"type":46},"2027-10-01",{"name":5,"class":6}]